Orsense - Non-Invasive Technologues

Please choose your location:

Latest News

Apr. 15, 2021
New Technology Makes Blood Donations Easier

Oct. 19-21, 2019
Come meet us at AABB annual meeting in San Antonio, on October 19-21, 2019- Booth #240

Sep. 3, 2019
OrSense NBM-200 Non-Invasive Hemoglobin Device Implemented by Children's Hospital Los Angeles

Jul. 11, 2019
OrSense NBM-200 Non-Invasive Hemoglobin Device Selected by the Central Blood Bank of Catalonia

Jun. 23-25, 2019
Meet us at the ISBT 29th Regional Congress at the Congress Center in Basel, Booth U109

May. 14, 2019
FDA Grants Market Clearance for the OrSense NBM200; the First Noninvasive Hemoglobin System Cleared for Use in Blood Donation Centers

Oct. 13-16, 2018
Meet us at the upcoming AABB annual meeting in Boston, on October 13-16, 2018- Booth #2824

Jun. 2-6, 2018
Meet us at the 35th International Congress of ISBT - Booth #1806


OrSense is a medical device company that develops and commercializes innovative non-invasive monitoring technologies for continuous and spot measurements of blood parameters.

Our products are based on our revolutionary, proprietary SpectOLightTM Occlusion Spectroscopy technology, enabling easy and accurate measurements of blood parameters under extreme conditions by overcoming key obstacles that hinder the performance of competing technologies. Our current focus is non-invasive hemoglobin testing for the detection of anemia in diverse clinical settings. 



Updated: March 2021
Get the Latest
Clinical Data